Jérôme Clerc

Years Active: 2021-2023
Publications (10 Years): 5

This page only lists publications with an associated author ORCID identifier.

Publications

Louis Schubert, Mohamed Lamine Mariko, Jérôme Clerc, Olivier Huillard, Lionel Groussin
MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data. Cancers 15 (3) (2023)
Louis Schubert, Mohamed Lamine Mariko, Jérôme Clerc, Olivier Huillard, Lionel Groussin
MAPK Pathway Inhibitors in Thyroid Cancer: Preclinical and Clinical Data. Cancers 15 (3) (2023)
Lionel Groussin, Hélène Theodon, Laura Bessiene, Leopoldine Bricaire, Fidéline Bonnet-Serrano, Béatrix Cochand-Priollet, Karen Leroy, Simon Garinet, Eric Pasmant, Jérémie Zerbit, Romain Seban, François Goldwasser, Jérôme Clerc, Anne Segolene Cottereau, Olivier Huillard
Redifferentiating Effect of Larotrectinib in NTRK -Rearranged Advanced Radioactive-Iodine Refractory Thyroid Cancer. Thyroid : official journal of the American Thyroid Association 32 (5) (2022)
Anne-Ségolène Cottereau, Michel Meignan, Christophe Nioche, Jérôme Clerc, Loic Chartier, Laetitia Vercellino, Olivier Casasnovas, Catherine Thieblemont, Irène Buvat
New Approaches in Characterization of Lesions Dissemination in DLBCL Patients on Baseline PET/CT. Cancers 13 (16) (2021)
Lionel Groussin, Laura Bessiene, Jennifer Arrondeau, Simon Garinet, Béatrix Cochand-Priollet, Audrey Lupo, Jérémie Zerbit, Jérôme Clerc, Olivier Huillard
Letter to the Editor: Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer. Thyroid : official journal of the American Thyroid Association 31 (10) (2021)

Jérôme Clerc.css-eqlu8i{font-size:small;padding-left:4px;}